Skip to main content

We narrowed to 27,839 results for: CAT

Showing: 851 - 900 of 27839 results
  1. pSAP

    Plasmid
    #206429
    Purpose
    A vector backbone domesticated for SapI (pCC1BAC-based), contains elements for selection, maintenance, and propagation in S. cerevisiae (TRP1) and E. coli (cat).
    Depositor
    Type
    Empty backbone
    Expression
    Bacterial and Yeast
    Available Since
    Jan. 19, 2024
    Availability
    Academic Institutions and Nonprofits only
  2. pG5ElbLuc

    Plasmid
    #89341
    Purpose
    The plasmid pG5ElbLuc was prepared from pG5E1bCAT by replacing the CAT gene (EcoRI and Sty I fragment) with the firefly luciferase gene (from pGEM-Luc) as a 1745bp StuI-Hind111 fragment.
    Depositor
    Type
    Empty backbone
    Use
    Luciferase
    Expression
    Mammalian
    Available Since
    May 16, 2017
    Availability
    Academic Institutions and Nonprofits only
  3. pAAV-CAG-NIR-GECO2G (AAV9)

    Viral Prep
    #159605-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-CAG-NIR-GECO2G (#159605). In addition to the viral particles, you will also receive purified pAAV-CAG-NIR-GECO2G plasmid DNA. CAG-driven expression of the near-infrared calcium indicator NIR-GECO2G. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Available Since
    Dec. 18, 2024
    Availability
    Academic Institutions and Nonprofits only
  4. pAAV-CAG-NIR-GECO2G (AAV2)

    Viral Prep
    #159605-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-CAG-NIR-GECO2G (#159605). In addition to the viral particles, you will also receive purified pAAV-CAG-NIR-GECO2G plasmid DNA. CAG-driven expression of the near-infrared calcium indicator NIR-GECO2G. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Available Since
    Dec. 18, 2024
    Availability
    Academic Institutions and Nonprofits only
  5. pAAV-CAG-NIR-GECO2G (AAV1)

    Viral Prep
    #159605-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-CAG-NIR-GECO2G (#159605). In addition to the viral particles, you will also receive purified pAAV-CAG-NIR-GECO2G plasmid DNA. CAG-driven expression of the near-infrared calcium indicator NIR-GECO2G. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    CAG
    Available Since
    Dec. 18, 2024
    Availability
    Academic Institutions and Nonprofits only
  6. pAAV-EF1a-iFlpV (AAV1)

    Viral Prep
    #140137-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-iFlpV (#140137). In addition to the viral particles, you will also receive purified pAAV-EF1a-iFlpV plasmid DNA. EF1a-driven, light-inducible iFlpV recombinase for spatiotemporally precise optogenomic modifications. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available Since
    Oct. 28, 2021
    Availability
    Academic Institutions and Nonprofits only
  7. pAAV-EF1a-iDreV (AAV1)

    Viral Prep
    #140136-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-iDreV (#140136). In addition to the viral particles, you will also receive purified pAAV-EF1a-iDreV plasmid DNA. EF1a-driven, light-inducible iDreV recombinase for spatiotemporally precise optogenomic modifications. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available Since
    Oct. 28, 2021
    Availability
    Academic Institutions and Nonprofits only
  8. pAAV-EF1a-iCreV (AAV1)

    Viral Prep
    #140135-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-iCreV (#140135). In addition to the viral particles, you will also receive purified pAAV-EF1a-iCreV plasmid DNA. EF1a-driven, light-inducible iCreV recombinase for spatiotemporally precise optogenomic modifications. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available Since
    Sept. 15, 2021
    Availability
    Academic Institutions and Nonprofits only
  9. pAAV-EF1a-Dio-ASAP5-Kv2.1-WPRE (AAV9)

    Viral Prep
    #225708-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-EF1a-Dio-ASAP5-Kv2.1-WPRE (#225708). In addition to the viral particles, you will also receive purified pAAV-EF1a-Dio-ASAP5-Kv2.1-WPRE plasmid DNA. EF1a-driven, Cre-dependent soma-targeted expression of genetically encoded voltage indicator ASAP5. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1α
    Available Since
    Sept. 22, 2025
    Availability
    Academic Institutions and Nonprofits only
  10. pAAV-hsyn-ASAP5-Kv2.1-WPRE (AAV1)

    Viral Prep
    #225707-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hsyn-ASAP5-Kv2.1-WPRE (#225707). In addition to the viral particles, you will also receive purified pAAV-hsyn-ASAP5-Kv2.1-WPRE plasmid DNA. Syn-driven, soma-targeted expression of genetically encoded voltage indicator ASAP5. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available Since
    Aug. 6, 2025
    Availability
    Academic Institutions and Nonprofits only
  11. pAAV-hSyn-JEDI-2P-WPRE (AAV9)

    Viral Prep
    #179464-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-hSyn-JEDI-2P-WPRE (#179464). In addition to the viral particles, you will also receive purified pAAV-hSyn-JEDI-2P-WPRE plasmid DNA. hSyn-driven expression of the genetically encoded voltage indicator JEDI-2P. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available Since
    Jan. 24, 2024
    Availability
    Academic Institutions and Nonprofits only
  12. pAAV-hSyn-JEDI-2P-Kv-WPRE (AAV9)

    Viral Prep
    #179463-AAV9
    Purpose
    Ready-to-use AAV9 particles produced from pAAV-hSyn-JEDI-2P-Kv-WPRE (#179463). In addition to the viral particles, you will also receive purified pAAV-hSyn-JEDI-2P-Kv-WPRE plasmid DNA. hSyn-driven expression (soma and AIS-localized) of the genetically encoded voltage indicator JEDI-2P. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available Since
    Jan. 24, 2024
    Availability
    Academic Institutions and Nonprofits only
  13. pAAV-hsyn-flex-Voltron-ST (AAV1)

    Viral Prep
    #119036-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-hsyn-flex-Voltron-ST (#119036). In addition to the viral particles, you will also receive purified pAAV-hsyn-flex-Voltron-ST plasmid DNA. Synapsin-driven, cre-dependent expression of genetically encoded fluorescent voltage indicator Voltron1 with a soma-targeting sequence. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    Syn
    Available Since
    April 10, 2019
    Availability
    Academic Institutions and Nonprofits only
  14. pAAV-EF1a-iFlpV (AAV PHP.eB)

    Viral Prep
    #140137-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-EF1a-iFlpV (#140137). In addition to the viral particles, you will also receive purified pAAV-EF1a-iFlpV plasmid DNA. EF1a-driven, light-inducible iFlpV recombinase for spatiotemporally precise optogenomic modifications. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available Since
    Oct. 18, 2021
    Availability
    Academic Institutions and Nonprofits only
  15. pAAV-EF1a-iDreV (AAV PHP.eB)

    Viral Prep
    #140136-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-EF1a-iDreV (#140136). In addition to the viral particles, you will also receive purified pAAV-EF1a-iDreV plasmid DNA. EF1a-driven, light-inducible iDreV recombinase for spatiotemporally precise optogenomic modifications. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available Since
    Nov. 29, 2021
    Availability
    Academic Institutions and Nonprofits only
  16. pAAV-EF1a-DIO-JEDI-2P-WPRE (AAV1)

    Viral Prep
    #179460-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-DIO-JEDI-2P-WPRE (#179460). In addition to the viral particles, you will also receive purified pAAV-EF1a-DIO-JEDI-2P-WPRE plasmid DNA. EF1a-driven, Cre-dependent expression of voltage indicator JEDI-2P. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Tags
    cEGFP (Cre-dependent)
    Available Since
    Aug. 22, 2022
    Availability
    Academic Institutions and Nonprofits only
  17. pAAV-EF1a-DIO-JEDI-2P-Kv-WPRE (AAV1)

    Viral Prep
    #179459-AAV1
    Purpose
    Ready-to-use AAV1 particles produced from pAAV-EF1a-DIO-JEDI-2P-Kv-WPRE (#179459). In addition to the viral particles, you will also receive purified pAAV-EF1a-DIO-JEDI-2P-Kv-WPRE plasmid DNA. EF1a-driven, Cre-dependent soma and AIS-localized expression of voltage indicator JEDI-2P. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Tags
    cEGFP (Cre-dependent)
    Available Since
    Aug. 23, 2022
    Availability
    Academic Institutions and Nonprofits only
  18. pAAV-EF1a-iCreV (AAV PHP.eB)

    Viral Prep
    #140135-PHPeB
    Purpose
    Ready-to-use AAV PHP.eB particles produced from pAAV-EF1a-iCreV (#140135). In addition to the viral particles, you will also receive purified pAAV-EF1a-iCreV plasmid DNA. EF1a-driven, light-inducible iCreV recombinase for spatiotemporally precise optogenomic modifications. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available Since
    Sept. 15, 2021
    Availability
    Academic Institutions and Nonprofits only
  19. pCas9

    Plasmid
    #167547
    Purpose
    Used for CRISPR-Cas9 mediated recombineering in Enterococcus. Can clone desired gRNA using BsaI digestion.
    Depositor
    Inserts
    chloramphenicol acetyl transferase
    pUC19 origin of replication
    Use
    CRISPR
    Expression
    Bacterial
    Available Since
    June 28, 2021
    Availability
    Academic Institutions and Nonprofits only
Showing: 851 - 900 of 27839 results